Company Filing History:
Years Active: 2020-2024
Title: Yong Man Kim: Innovator in Cancer Treatment
Introduction
Yong Man Kim is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of cancer treatment through his innovative methods and compositions. With a total of 3 patents to his name, Kim is recognized for his groundbreaking work in producing natural killer cells.
Latest Patents
One of Yong Man Kim's latest patents is a method for producing natural killer cells and a composition for treating cancer. This method involves isolating peripheral blood mononuclear cells (PBMCs) from a blood sample. It further includes isolating at least one of CD56+ cells and/or CD3−/CD56+ cells from the PBMCs. The process also entails co-culturing these cells with a combination of feeder cells in the presence of a cytokine. The resulting composition comprises the CD56+ natural killer cells produced by this method along with a cytokine, showcasing a promising approach to cancer treatment.
Career Highlights
Yong Man Kim is associated with Nkmax Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention in the scientific community, particularly for its potential applications in immunotherapy.
Collaborations
Kim collaborates with notable colleagues, including Sang Woo Park and Jae Seob Jung. Their combined expertise contributes to the innovative projects at Nkmax Co., Ltd.
Conclusion
Yong Man Kim's contributions to the field of cancer treatment through his innovative methods and patents highlight his role as a leading inventor. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes in cancer therapy.